Literature DB >> 29404926

Synergistical action of the β2 adrenoceptor and fatty acid binding protein 2 polymorphisms on the loss of glomerular filtration rate in Chinese patients with type 2 diabetic nephropathy.

Tao Wang1, Yan Zhang2, Ning Wang3, Qiong Liu4, ZeKai Wang4, Bing Liu4, Kai Niu4.   

Abstract

PURPOSE: Since altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the effect of polymorphic Arg16Gly and Gln27Glu in the β2 adrenoceptor gene and Ala54Thr in the fatty acid binding protein 2 gene on the estimated glomerular filtration rate (eGFR) in Chinese patients with the above disease.
METHODS: A total of 552 diabetic subjects recruited from annual health examinations were studied. The eGFR was calculated from the Modification of Diet in Renal Disease equation for the Chinese. Plasma norepinephrine level and genotype were determined by high-performance liquid chromatography-tandem mass spectrometry and TaqMan method, respectively. Holter-derived heart rate viability (HRV) and the MRI-generated renal apparent diffusion coefficient (ADC) were evaluated.
RESULTS: The Gly16Gly and Thr54Thr homozygotes had significantly higher microalbuminuria and lower eGFR against other genotypes in their individual polymorphism. Besides, the Gly16Gly variant exhibited markedly elevated norepinephrine level, whereas indicative of insulin resistance was increased in the Thr54Thr one. Multiple linear regression analysis further confirmed the independent genetic effect on the eGFR. Moreover, multifactor dimensionality reduction method detected a gene-gene synergistic action that subjects with the Gly16Gly/Thr54Thr genotype were exposed to higher risk of eGFR loss. Finally, these findings were accompanied by lower HRV and ADC, indicating sympathetically mediated hemodynamic changes.
CONCLUSIONS: By uncovering the genetic component of the coherent interplay between the elevated sympathetic nerve activity and metabolic disorders, our observations might promote the development of novel personalized prevention and management strategies against the diabetic nephropathy, especially in the genetically susceptible individuals.

Entities:  

Keywords:  Diabetic nephropathy; Fatty acid binding protein-2; Single nucleotide polymorphism; Type 2 diabetes; β2-Adrenergic receptor

Mesh:

Substances:

Year:  2018        PMID: 29404926     DOI: 10.1007/s11255-018-1812-2

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  32 in total

1.  Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation.

Authors:  Kazuko Masuo; Hideki Kawaguchi; Hiroshi Mikami; Toshio Ogihara; Michael L Tuck
Journal:  Hypertension       Date:  2003-09-02       Impact factor: 10.190

2.  Association of genetic variants with chronic kidney disease in Japanese individuals with type 2 diabetes mellitus.

Authors:  Tetsuro Yoshida; Kimihiko Kato; Kiyoshi Yokoi; Sachiro Watanabe; Norifumi Metoki; Hidemi Yoshida; Kei Satoh; Yukitoshi Aoyagi; Yutaka Nishigaki; Takao Suzuki; Yoshinori Nozawa; Yoshiji Yamada
Journal:  Int J Mol Med       Date:  2009-04       Impact factor: 4.101

Review 3.  Endothelial dysfunction as a potential contributor in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Katsuyuki Tanabe; Byron P Croker; Richard J Johnson; Maria B Grant; Tomoki Kosugi; Qiuhong Li
Journal:  Nat Rev Nephrol       Date:  2010-11-02       Impact factor: 28.314

4.  Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis.

Authors:  Yuqing Chen; Michael S Lipkowitz; Rany M Salem; Maple M Fung; Vibha Bhatnagar; Manjula Mahata; Caroline M Nievergelt; Fangwen Rao; Sushil K Mahata; Nicholas J Schork; Pamela J Hicks; Donald W Bowden; Barry I Freedman; Victoria H Brophy; Daniel T O'Connor
Journal:  Am J Nephrol       Date:  2010-05-19       Impact factor: 3.754

5.  Arg16Gly and Gln27Glu β2 adrenergic polymorphisms influence cardiac autonomic modulation and baroreflex sensitivity in healthy young Brazilians.

Authors:  Magda M Atala; Alessandra Goulart; Grazia M Guerra; Cristiano Mostarda; Bruno Rodrigues; Priscila R Mello; Dulce E Casarine; Maria-Claudia Irigoyen; Alexandre C Pereira; Fernanda M Consolim-Colombo
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

Review 6.  Sympathetic regulation of renal function in stroke-prone spontaneously hypertensive rats congenic for chromosome 1 blood pressure quantitative trait loci.

Authors:  Tao Wang; Toshikazu Takabatake; Yuta Kobayashi; Toru Nabika
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-06-18       Impact factor: 2.557

Review 7.  Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases.

Authors:  Kirsten Leineweber; Gerd Heusch
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

8.  Sympathetic regulation of the renal functions in rats reciprocally congenic for chromosome 1 blood pressure quantitative trait locus.

Authors:  Tao Wang; Toru Nabika; Yoshitomo Notsu; Toshikazu Takabatake
Journal:  Hypertens Res       Date:  2008-03       Impact factor: 3.872

9.  Renal diffusion-weighted imaging in diabetic nephropathy: correlation with clinical stages of disease.

Authors:  Pınar Cakmak; Ahmet Baki Yağcı; Belda Dursun; Duygu Herek; Semin Melahat Fenkçi
Journal:  Diagn Interv Radiol       Date:  2014 Sep-Oct       Impact factor: 2.630

Review 10.  Relationship between chronic kidney disease and metabolic syndrome: current perspectives.

Authors:  Khaled Nashar; Brent M Egan
Journal:  Diabetes Metab Syndr Obes       Date:  2014-09-18       Impact factor: 3.168

View more
  1 in total

1.  Correlation between Blood Oxygen Level-Dependent Magnetic Resonance Imaging Images and Prognosis of Patients with Multicenter Diabetic Nephropathy on account of Artificial Intelligence Segmentation Algorithm.

Authors:  Yifan Zhang; Xiaohan Wang; Zhaoyu Lin; Guojian Shao; Renban Wang; Zhoutao Xie
Journal:  Comput Math Methods Med       Date:  2022-07-11       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.